Dr Misra has extensively researched on the causes of diabetes.
The recent Quality in Care Diabetes awards celebrated 11 years of recognising, rewarding and sharing initiatives that improve the quality of life for people living with diabetes.
The exceptional work undertaken during the unprecedented pressure of Covid-19 was recognised in this year’s finalists and the results were recently announced in a ceremony at Sanofi’s offices in Reading, presented by Alan Dedicoat.
Among the winners was Dr Shivani Misra – who was presented with the Outstanding Contribution Award for Services in Diabetes.
Dr Misra is a Consultant in Metabolic Medicine and Diabetes at Imperial College London Healthcare NHS Trust and an Honorary Research Fellow within Imperial College London.
She is an NIHR Clinical Champion in Diabetes Stratified Medicine and has been awarded a Future Leaders Mentorship Awarded from the European Federation for the Study of Diabetes (2017).
Dr Misra led the DRWF-funded MY DIABETES study, which recruits at over 40 sites around England and phenotypes young-onset diabetes in different ethnic groups. This outstanding work is why she has been recognised in 2021.
In addition, Dr Misra is a member of the DRWF Board of Trustees.
Dr Misra said: “I am delighted to have received this award and slightly shocked! To be recognised for outstanding contributions to services in diabetes, by NHS England is simply wonderful.
“It feels like not just an award to me but for the entire team I work with. The award was based around the work I’ve undertaken, both clinical and research, in supporting classification of diabetes in people from minority ethnic groups and drawing attention to early-onset type 2 diabetes which is a growing and concerning problem.
“Of course, it was my DRWF Sutherland-Earl Fellowship (many years ago) that got me hooked on this area of work and I am truly humbled and feel very privileged to have my research and work recognised in a way that shows it has been of benefit to people living with diabetes.”
DRWF is proud to be a support partner for the QiC Diabetes Awards.
Sarah Tutton, DRWF Chief Executive, said: “These awards provide a truly collaborative environment within which to share information and innovation in care delivery. We are delighted to support the QiC Diabetes programme and share in this recognition of achievement of inspiring and dedicated people. Even more so given the relentless challenges of the pandemic period, and the unwavering efforts that everyone put in to ensure that people with diabetes continued to receive the best quality care and support. We are immensely proud of Dr Misra and her commitment to the diabetes community.”